The first vaccine designed to prevent infection with the lethal Ebola virus has passed initial safety tests in humans and has shown promising signs that it may protect people from contracting the disease, government scientists reported Friday.
Just 21 people received the experimental vaccine in the early stage testing. Much more research is necessary to prove whether the vaccine will prove successful, cautioned lead researcher Dr. Gary Nabel of the National Institutes of Health.
Still, the results are encouraging for U.S. scientists who worry not only that the horrific virus might be used as a terror weapon but note that natural outbreaks in Africa seem to be on the rise.
Ebola hemorrhagic fever kills within days by causing massive internal bleeding. There is no cure. Ebola is highly contagious, and up to 90 percent of people who catch it die.
Medicine Tag
Health Tag
No comments:
Post a Comment